The global health and economic value of COVID-19 vaccination.
J P SevillaDaria BurnesJoseph S KneeManuela Di FuscoMoe H KyawJingyan YangJennifer L NguyenDavid E BloomPublished in: BMJ global health (2024)
We provide the first estimates of the broad value of CV incorporating GDP, QALY and direct and indirect cost impacts. Through December 2021, CV produced significant health and economic value, represented strong value for money and produced significant macroeconomic benefits that should be considered in vaccine evaluation.